Scribe Therapeutics Inc.
SCTX
IPO
$29.41
-$1.93-6.16%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 43.01M | 49.73M | -- | ||
| Total Receivables | 1.23M | 1.52M | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 865.00K | 1.15M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 45.11M | 52.40M | -- | ||
|
|
|||||
| Total Current Assets | 45.11M | 52.40M | -- | ||
| Net Property, Plant & Equipment | 8.54M | 9.32M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 4.29M | 3.49M | -- | ||
| Total Assets | 57.93M | 65.21M | -- | ||
|
|
|||||
| Total Accounts Payable | 2.77M | 5.12M | -- | ||
| Total Accrued Expenses | 7.40M | 4.33M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 39.17M | 41.87M | -- | ||
| Total Finance Division Other Current Liabilities | 29.35M | 28.40M | -- | ||
| Total Other Current Liabilities | 29.35M | 28.40M | -- | ||
| Total Current Liabilities | 78.70M | 79.72M | -- | ||
|
|
|||||
| Total Current Liabilities | 78.70M | 79.72M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 4.10M | 4.46M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 19.62M | 19.41M | -- | ||
| Total Liabilities | 102.42M | 103.59M | -- | ||
|
|
|||||
| Common Stock & APIC | 16.69M | 16.32M | -- | ||
| Retained Earnings | -181.53M | -175.05M | -- | ||
| Treasury Stock & Other | -2.00K | -- | -- | ||
| Total Common Equity | -164.85M | -158.74M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 120.36M | 120.36M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 120.36M | 120.36M | -- | ||
|
|
|||||
| Total Common Equity | -164.85M | -158.74M | -- | ||
| Total Preferred Equity | 120.36M | 120.36M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -44.49M | -38.38M | -- | ||
|
|
|||||